AlphaYouAC
Insider selling
Abraham Ceesay sold $2.4M of Rapport Therapeutics, Inc. (RAPP) stock
Abraham Ceesay, Chief Executive Officer of Rapport Therapeutics, Inc. (RAPP), sold 51,499 shares of RAPP stock worth $2.4M, per an SEC Form 4 filed Aug 12, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Aug 10, 2026, 2 days before it was made public.
RAPP has moved -15.6% since the trade date, from $46.98 to $39.66 (Sep 21, 2026 close).
- Traded
- Aug 10, 2026
- Disclosed
- Aug 12, 2026
- Filing delay
- 2 days
- Price since
- -15.6%
- Role
- Chief Executive Officer
- Source
- SEC Form 4
More RAPP insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.